Technical Analysis for KNSA - Kiniksa Pharmaceuticals, Ltd.

Grade Last Price % Change Price Change
grade F 13.68 -0.65% -0.09
KNSA closed down 5.17 percent on Friday, July 12, 2019, on 58 percent of normal volume.
1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical KNSA trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish -0.65%
MACD Bearish Centerline Cross Bearish -0.65%
Down 3 Days in a Row Weakness -0.65%
Fell Below 50 DMA Bearish -5.79%
Calm After Storm Range Contraction -5.79%
NR7 Range Contraction -5.79%
Upper Bollinger Band Walk Strength -5.79%
MACD Bullish Centerline Cross Bullish -9.40%
Upper Bollinger Band Walk Strength -9.40%
Inside Day Range Contraction -9.40%

Older signals for KNSA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.
Biotechnology Health Biopharmaceutical Pharmaceutical Industry Diseases Medication Pharmaceutical Industry In China Pharmacology
Is KNSA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jun 29 Is Kiniksa Pharmaceuticals, Ltd. (KNSA) A Good Stock To Buy ?
Jun 20 Kiniksa Pharmaceuticals (KNSA) Investor Presentation - Slideshow
Jun 12 Kiniksa Presents Preclinical Data on the GM-CSF Signaling Pathway in Temporal Arteries of GCA Patients at the Annual European Congress of Rheumatology 
Jun 10 The Kiniksa Pharmaceuticals (NASDAQ:KNSA) Share Price Is Down 23% So Some Shareholders Are Getting Worried
Jun 5 Mixed shelf filing roundup - healthcare
May 30 Kiniksa to Present Preclinical Data on the GM-CSF Signaling Pathway in Temporal Arteries of GCA Patients at EULAR 2019
May 29 Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
May 16 Kiniksa to Present Data on the Burden of Disease in Patients with Recurrent Pericarditis at the International Society for Pharmacoeconomics and Outcomes Research
May 13 Kiniksa Presents Clinical and Preclinical Data for KPL-716 at the 77th Annual Meeting of the Society for Investigative Dermatology
May 2 Kiniksa Pharmaceuticals reports Q1 results
See more KNSA news...
Indicators
Indicator Value
52 Week High 32.88
52 Week Low 13.04
Average Volume 100,966
200-Day Moving Average 18.541
50-Day Moving Average 14.6708
20-Day Moving Average 14.0325
10-Day Moving Average 14.364
Average True Range 1.0873
ADX 13.44
+DI 24.4214
-DI 20.9272
Chandelier Exit (Long, 3 ATRs ) 13.7181
Chandelier Exit (Short, 3 ATRs ) 16.3219
Upper Bollinger Band 15.3446
Lower Bollinger Band 12.7204
Percent B (%b) 0.4
BandWidth 18.700873
MACD Line -0.0238
MACD Signal Line -0.1419
MACD Histogram 0.1181
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.99
Resistance 3 (R3) 15.12 14.84 14.78
Resistance 2 (R2) 14.84 14.53 14.78 14.71
Resistance 1 (R1) 14.31 14.34 14.17 14.18 14.65
Pivot Point 14.03 14.03 13.97 13.97 14.03
Support 1 (S1) 13.50 13.72 13.36 13.37 12.89
Support 2 (S2) 13.22 13.53 13.16 12.83
Support 3 (S3) 12.69 13.22 12.76
Support 4 (S4) 12.56